Nestlé agreed to divest its entire mainstream Vitamins, Minerals and Supplements business—including the Holistic Health portfolio—to a private equity firm for approximately $1 billion in a transaction slated to close August 2026. The buyer remains unnamed. The sale strips Nestlé of a category it has deprioritized for five years while health-conscious consumers migrated to vertically integrated wellness brands and DTC platforms that deliver margin expansion the food conglomerate could not replicate.

The VMS business generated low-single-digit growth and mid-teen EBITDA margins, far below Nestlé's core nutrition and beverage segments that run 22-24% EBITDA. Management signaled in prior calls that the unit lacked the scale to justify capital allocation against higher-return coffee, pet care, and infant formula franchises. The $1 billion price tag implies a 6.5-7.0x EBITDA multiple if the business cleared $140-150 million in trailing cash flow—a modest premium to food CPG comps but below the 8-10x multiples specialist supplement platforms command when paired with owned manufacturing and Amazon velocity.

The divestiture accelerates Nestlé's pivot toward premiumization and away from commoditized shelf staples. Private equity interest in VMS remains acute: CVC, Blackstone, and KKR have deployed $18 billion into wellness and nutrition assets since 2022, banking on DTC conversion, margin reengineering, and eventual roll-up exits to strategics or SPACs. The unnamed buyer inherits a brand portfolio that still holds retail distribution but lacks the influencer economics and clinical credentialing that drive repeat purchase in the $50 billion U.S. supplement market. Margin improvement will hinge on supply chain consolidation, SKU rationalization, and migration to higher-AOV subscription models—standard PE playbook work that Nestlé chose not to fund.

Allocators should track two developments through Q3 2026. First, whether the buyer is a specialist healthcare PE shop like L Catterton or Freeland Ventures, which would signal operational upside through platform bolt-ons, or a generalist fund treating this as yield-on-cost with minimal integration risk. Second, watch for Nestlé's capital redeployment: $1 billion in proceeds lands during a period when the company faces activist pressure to sharpen portfolio focus and return cash. Management has $4.2 billion in share buyback capacity authorized through 2027, and this sale could fund accelerated repurchases or fund a counterbid in premium petfood, where Nestlé already holds Purina and has expressed interest in tuck-in M&A.

The transaction confirms what the largest food multinationals learned over the past three years: margin-dilutive brands with no moat and no data flywheel do not survive internal capital competition. Nestlé exits with a clean $1 billion and no obligation to compete in a category where smaller, faster operators already own the customer relationship.